Idursulfase

Elaprase 2 MG/ML Concentrado Para Solucion Para Perfusion

2 mg concentrado para solución para perfusiónSpainMarketedAuthorised 7 Feb 2007

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Idursulfase

Elaprase 2 MG/ML Concentrado Para Solucion Para Perfusion

2 mg concentrado para solución para perfusiónSpainMarketedAuthorised 7 Feb 2007

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Elaprase 2 mg/ml, concentraat voor oplossing voor infusie 6 mgNetherlands · Concentraat voor oplossing voor infusie · Takeda Pharmaceuticals International AG Ireland Branch

ElapraseNew Zealand · Inj 2 mg per ml, 3 ml vial

ELAPRASE 2mg/mlRomania · 2mg/ml · conc. pt. sol. perf. · Shire Human Genetic Therapies AB

Elaprase®Serbia · 2mg/mL · koncentrat za rastvor za infuziju · Takeda DOO

ELAPRASE 2 mg/ml concentrate for solution for infusionSaudi Arabia · Cangene BioPharma Inc. (CBI)

ELAPRASE 2 mg/ml concentrate for solution for infusionSaudi Arabia · Baxter Pharmaceutical Solution LLC

Elaprase (TM) Solution for Intravenous Infusion 2mg/ mlSingapore · 6.0 mg/vial · infusion, solution concentrate · Sanofi-Aventis Singapore Pte. LTD.

ElapraseUnited States · 6MG/3ML · injectable · Shire

Packs

Pack	Code	Status
ELAPRASE 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 3 ml	658306

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Idursulfase
Strength: 2 mg
Dosage form: concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 7 Feb 2007
Registration: 06365001
Marketing authorisation holder: Takeda Pharmaceuticals International Ag Ireland Branch
Procedure: EU centralised
Supply: Uso Hospitalario